Literature DB >> 465992

Balanitis xerotica obliterans.

A A Khezri, A Dounis, M Dunn.   

Abstract

Twenty patients with histologically proven balantis xerotica obliterans have undergone different forms of treatment; their progress has been reviewed and discussed. Balanitis xerotica obliterans involving only the foreskin was best treated by circumcision. The patients in whom meatal stenosis was present responded well to regular meatal dilatation, meatotomy followed by regular dilatation and, in advanced cases, to meatoplasty. At present there is no evidence to indicate that associated urethral strictures, proximal to the fossa navicularis, are due to balanitis xerotica obliterans.

Entities:  

Mesh:

Year:  1979        PMID: 465992     DOI: 10.1111/j.1464-410x.1979.tb02873.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  Squamous cell carcinoma of the penis arising from balanitis xerotica obliterans.

Authors:  X Giannakopoulos; K Basioukas; S Dimou; N Agnantis
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  Do men having routine circumcision need histological confirmation of the cause of their phimosis or postoperative follow-up?

Authors:  I Pearce; S R Payne
Journal:  Ann R Coll Surg Engl       Date:  2002-09       Impact factor: 1.891

3.  Perineostomy: the last oportunity.

Authors:  Juan Carlos Regueiro Lopez; Enrique Gomez Gomez; Alberto Alonso Carrillo; Roque Cano Castineira; Maria Jose Requena Tapia
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

4.  Fossa navicularis strictures due to 22F catheters used in robotic radical prostatectomy.

Authors:  David S Yee; Thomas E Ahlering; Joel Gelman; Douglas W Skarecky
Journal:  JSLS       Date:  2007 Jul-Sep       Impact factor: 2.172

5.  Larger urethral catheter size leads to fossa navicularis stricture formation in robotic radical prostatectomy.

Authors:  David S Yee; Joel Gelman; Douglas W Skarecky; Thomas E Ahlering
Journal:  J Robot Surg       Date:  2007-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.